Trial intelligence / Profile preview

BOTOX for Thoracic Outlet Syndrome

NCT00444886Phase 2Completed

Sponsor
University of British Columbia
Start
May 2007
Primary completion
Feb 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of botulinum toxin type A in thoracic outlet syndrome (TOS), sponsored by University of British Columbia. Started May 2007; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

thoracic outlet syndrome (TOS)

Beyond the preview

Go deeper on NCT00444886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00444886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call